Publications by authors named "Ayalew Tefferi"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,062

Total Likes

1,054

Extended Reach

814,870

Social Features

408
E
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Ayalew Tefferi, Alessandro Maria Vannucchi, Tiziano Barbui

Am J Hematol· April 2024

Videos about Article: user user

2 178

View All Article and Social Media Activity
P
Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
Ayalew Tefferi, Tiziano Barbui

September 2023

Videos about Article: user user

2 4 226 2

View All Article and Social Media Activity
L
Low (0.1% to ≤ 1%) or Very Low (0.06% to < 0.1%) JAK2V617F Allele Burden in Routine Testing: Clinical Correlates and Clonal Trajectory.
Ruah Alyamany, Ahmed Alnughmush, Oleksandr Klymenko, Mohammad Alhousani, Animesh Pardanani, Ayalew Tefferi

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study.
Irfan Yasin, Anna Stengel, Haipeng Shao, Amandeep Kaur, Emily F Mason, Ayalew Tefferi

Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutations and variants in myeloid neoplasms: associated phenotypes, co-mutations, and survival trends.
Abiola Bolarinwa, Natasha Szuber, Rong He, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute leukemia of ambiguous lineage with -alterations in adults.
Steven Tessier, Patricia T Greipp, Dragan Jevremovic, Hassan B Alkhateeb, Aref Al-Kali, Ayalew Tefferi

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-relevant misdiagnosis of autoimmune myelofibrosis.
Naseema Gangat, Kaaren K Reichard, Attilio Orazi, David S Viswanatha, Curtis A Hanson, Ayalew Tefferi

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloproliferative Neoplasms-Unclassifiable (MPN-U): A Carefully Curated Series of 30 Mayo Clinic Patients.
Rania M Abdelaziz, Priyansh Faldu, Saubia Fathima, Cinthya J Zepeda Mendoza, Animesh Pardanani, Ayalew Tefferi

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of BLAST and BLAST-Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo-Humanitas Collaborative Project Involving 1101 Patients.
Saubia Fathima, Ali Alsugair, Muhammad Yousuf, Priyansh Faldu, Clifford Csizmar, Ayalew Tefferi

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Concurrent (Double-Positive) JAK2, CALR, or MPL Mutations and Corresponding Clinicopathologic Features: Analysis of 21556 Mayo Clinic NGS Studies Including 2651 Informative Cases.
Rong He, Paul L Ollila, Xi Zhang, Ji Yuan, Min Shi, Ayalew Tefferi

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia.
Benjamin McCormick, Anthony Findley, Kendall Diebold, Garrett Bourne, Maris Hardee, Ayalew Tefferi

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hemojuvelin-Hepcidin Axis as a Target for the Treatment of Anemia or Conversely Polycythemia.
Naseema Gangat, Ayalew Tefferi

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2 Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management.
Naseema Gangat, Natasha Szuber, Ayalew Tefferi

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SH2B3 (Lnk) Mutations in Myeloid Neoplasms: Morphologic Spectrum, Co-Mutation Patterns, and Clinical Correlates.
Ayalew Tefferi, Muhammad Yousuf, Sam J Wu, Yassin A Bashir, Saubia Fathima

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myelomonocytic leukaemia.
Ayalew Tefferi, Mrinal M Patnaik

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2 wild-type erythrocytosis: concept, differential diagnosis, diagnostic steps, and treatment approaches.
Natasha Szuber, Ayalew Tefferi, Naseema Gangat

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple A Plus (AAA ) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients.
Ayalew Tefferi, Giuseppe G Loscocco, Lior Rokach, Tamar Tadmor, Priyansh Faldu

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation profiling of chronic myeloproliferative neoplasms: improving clinical-molecular prognostic models.
Giuseppe G Loscocco, Naseema Gangat, Paola Guglielmelli, Alessandro M Vannucchi, Ayalew Tefferi

Expert Rev Mol Diagn· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis.
Monia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas, Alberto Alvarez-Larran, Prithviraj Bose, Ayalew Tefferi

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct clinical, laboratory, molecular, and pathologic features of systemic mastocytosis involving the gastrointestinal tract.
April Chiu, David S Viswanatha, Rong He, Julie A Majerus, Kaaren K Reichard, Ayalew Tefferi

Am J Clin Pathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloproliferative neoplasms with clinically relevant paroxysmal nocturnal hemoglobinuria: clinical correlations and outcomes.
Priyansh Faldu, Rania Abdelaziz, Muhammad Yousuf, Animesh Pardanani, Mrinal Patnaik, Ayalew Tefferi

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia.
Guillermo Montalban-Bravo, Sanam Loghavi, Ziyi Li, Kelly Chien, Rashmi Kanagal-Shamanna, Ayalew Tefferi

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia.
Tiziano Barbui, Jürgen Thiele, Arianna Ghirardi, Hans Michael Kvasnicka, Umberto Gianelli, Ayalew Tefferi

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients.
Ali Alsugair, Estefania Gauto Mariotti, Mohammad M Alhousani, Saubia Fathima, Muhammad Yousuf, Ayalew Tefferi

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective analysis of upfront treatment strategies in chronic myelomonocytic leukemia: impact on survival and response patterns.
Muhammad Yousuf, Priyansh Faldu, Maymona Abdelmagid, Fnu Aperna, Saubia Fathima, Ayalew Tefferi

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System.
Fnu Aperna, Maymona G Abdelmagid, Mahesh Kumar, Joseph H Butterfield, Thanai Pongdee, Ayalew Tefferi

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes.
Clifford M Csizmar, Anuya Natu, Mark Gurney, Saubia Fathima, Ali Khalid A Alsugair, Ayalew Tefferi

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis